Exponent (EXPO) is entering a leadership transition, with Dr. John D. Pye set to become President and Eric Anderson moving into the CFO role on May 1, 2026, along with broader board changes.

Despite the leadership shuffle, investor sentiment has been cautious, with the 30 day share price return of 6.65% and a 1 year total shareholder return decline of 17.28% pointing to fading momentum over both shorter and longer periods.

If you are reassessing Exponent after these leadership changes, it can help to widen your search and look at other companies shaping their sectors through 18 top founder-led companies

With Exponent’s shares down over the past year despite ongoing revenue and net income growth, and trading below some estimated value markers, the key question now is whether this reset reflects an opportunity or if the market is already pricing in future growth.

Most Popular Narrative: 27.4% Undervalued

With Exponent's fair value narrative set at $90 against a last close of $65.37, the current gap hinges on how durable its consulting demand really is.

The intensifying focus on safety, risk management, and product reliability, especially in emerging fields such as advanced driver assistance systems, battery storage, and wearables, is positioning Exponent as a preferred partner for critical litigation and proactive risk projects, which should help sustain premium pricing and secure net margins as these markets expand.

Curious what earnings path and margin profile support this fair value, and why the narrative leans on a premium profit multiple rather than industry averages.

Result: Fair Value of $90 (UNDERVALUED)

However, sustained margin pressure and softer utilization, along with slower growth in key regulatory and chemical work, could challenge the premium P/E narrative that investors are leaning on.

Another View: Multiples Point To A Richer Price Tag

That $90 fair value hinges on a premium profit multiple, but current market ratios already look demanding. Exponent trades on a P/E of 30.4x, versus an industry average of 18.6x and a fair ratio of 17.7x, which suggests limited room for multiple expansion if sentiment cools.

For you, the question is whether that premium is a quality badge worth paying for or a valuation risk if earnings or margins fall short of expectations, especially with mixed signals on recent growth and utilization trends.

Next Steps

If the mixed signals in this article leave you undecided, it can pay to move quickly and study the balance of risks and rewards yourself by starting with 4 key rewards and 1 important warning sign

Looking for more investment ideas?

If Exponent leaves you on the fence, do not stop here. Broaden your watchlist with a few focused ideas that match how you like to invest.

• Target quality at a discount by reviewing companies highlighted in the 58 high quality undervalued stocks.
• Prioritize resilience and sleep easier at night by checking out businesses identified through the 72 resilient stocks with low risk scores.
• Spot potential early-stage opportunities with stronger balance sheets by scanning the 33 elite penny stocks with strong financials.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.